Anti-eIF3A antibody
5
(2 Reviews)
|
(10 Publications)
Rabbit Polyclonal EIF3A antibody. Suitable for IHC-P, IP, WB and reacts with Mouse, Human samples. Cited in 10 publications. Immunogen corresponding to Synthetic Peptide within Human EIF3A.
View Alternative Names
EIF3S10, KIAA0139, EIF3A, Eukaryotic translation initiation factor 3 subunit A, eIF3a, Eukaryotic translation initiation factor 3 subunit 10, eIF-3-theta, eIF3 p167, eIF3 p180, eIF3 p185
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-eIF3A antibody (AB86146)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human prostate carcinoma (left) and mouse teratoma (right) tissues labelling eIF3A with ab86146 at 1/200 (1µg/ml). Detection : DAB.
- WB
AbReview41283****
Western blot - Anti-eIF3A antibody (AB86146)
All lanes:
Western blot - Anti-eIF3A antibody (ab86146) at 1/1000 dilution
All lanes:
Human U2OS osteosarcoma whole cell lysate at 20 µg
Secondary
All lanes:
IRDye® 800CW conjugated donkey anti-rabbit polyclonal at 1/15000 dilution
Predicted band size: 166 kDa
Observed band size: 166 kDa
false
Exposure time: 5min
This image is courtesy of an anonymous Abreview
- WB
AbReview41310****
Western blot - Anti-eIF3A antibody (AB86146)
All lanes:
Western blot - Anti-eIF3A antibody (ab86146) at 1/1000 dilution
All lanes:
Mouse pancreatic cancer whole cell lysate at 20 µg
Secondary
All lanes:
IRDye® 680LT-conjugated donkey anti-mouse IgG polyclonal at 1/15000 dilution
Predicted band size: 166 kDa
Observed band size: 166 kDa
false
Exposure time: 10min
This image is courtesy of an anonymous Abreview
- WB
Unknown
Western blot - Anti-eIF3A antibody (AB86146)
All lanes:
Western blot - Anti-eIF3A antibody (ab86146) at 0.04 µg/mL
Lane 1:
HeLa whole cell lysate at 50 µg
Lane 2:
HeLa whole cell lysate at 15 µg
Lane 3:
HeLa whole cell lysate at 5 µg
Lane 4:
293T whole cell lysate at 50 µg
Lane 5:
NIH3T3 whole cell lysate at 50 µg
Predicted band size: 166 kDa
true
Exposure time: 3s
- IP
Unknown
Immunoprecipitation - Anti-eIF3A antibody (AB86146)
Detection of Human eIF3A by Immunoprecipitation, using ab86146 at 3µg/mg lysate. Image shows immunoprecipitated eIF3A detected with post IP WB, loading 20% of IP and using HeLa whole cell lysate at 1mg, with an antibody recognising an upstream epitope in lane 1, ab86146 at 1 µg/ml in lane 2 and control IgG in lane 3. Detection : Chemiluminescence with an exposure time of 3 seconds.
All lanes:
Immunoprecipitation - Anti-eIF3A antibody (ab86146)
Predicted band size: 166 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
EIF3A is a central component of the eIF3 complex which consists of multiple subunits that interact to facilitate the beginning of translation. It supports the recruitment of mRNA to the small ribosomal subunit mediating the formation of the 43S pre-initiation complex. Its activity influences multiple downstream biological processes including cell growth and proliferation highlighting its essential role in maintaining normal cellular functions.
Pathways
EIF3A is integral to the mTOR signaling pathway which is important for regulating cell growth and protein synthesis. In this pathway eIF3A works closely with proteins like mTOR and Raptor interacting to control the translation initiation machinery. Additionally eIF3A contributes to the regulation of the Wnt signaling pathway which is important for cell proliferation and differentiation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (10)
Recent publications for all applications. Explore the full list and refine your search
Acta pharmaceutica Sinica. B 15:1571-1588 PubMed40370535
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of hematology & oncology 17:7 PubMed38302992
2024
Applications
Unspecified application
Species
Unspecified reactive species
NAR cancer 4:zcab050 PubMed35047824
2022
Applications
Unspecified application
Species
Unspecified reactive species
iScience 25:103645 PubMed35005567
2022
Applications
Unspecified application
Species
Unspecified reactive species
Genome medicine 13:183 PubMed34798904
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cancer 19:40 PubMed32106857
2020
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cell 73:775-787.e10 PubMed30642763
2019
Applications
Unspecified application
Species
Unspecified reactive species
Cell 176:491-504.e21 PubMed30612740
2019
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 9:796 PubMed30038300
2018
Applications
WB
Species
Human
PloS one 8:e56272 PubMed23405269
2013
Applications
IP
Species
Human
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com